Share Your Research, Maximize Your Social Impacts
PROSPECTS OF RIVAROXABAN USE IN THE TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
Journal: Oriental Reniassance: Innovative, educational, natural and social sciences (Vol.1, No. 11)Publication Date: 2021-12-09
Authors : Buvamukhamedova Nasiba Tokhirovna; Jabbarov Ozimbay Otakhanovich; Mirzayeva Gulchekhra Fayzullaevna; Madazimova Dilrukh Khayatjanovna;
Page : 496-502
Keywords : chronic IHD; prognosis; efficacy and safety of therapy; antiaggregants; rivaroxaban;
Source : Download
Find it from : Google Scholar
Abstract
The review is devoted to the analysis of ways to influence hemostasis in order to improve the prognosis of patients with chronic ischemic heart disease (IHD). The results of the most significant randomized clinical trials evaluating the efficacy and safety of dual antiplatelet therapy in the treatment of patients with chronic IHD are discussed. The use of rivaroxaban in addition to acetylsalicylic acid (ASA) to reduce the risk of cardiovascular events in patients with chronic IHD was substantiated.
Other Latest Articles
- BUXORO VILOYATI SUG'ORILADIGAN O'TLOQI ALLYUVIAL TUPROQLARINING UMUMIY FIZIK XOSSALARI
- TABIIY IPAKDAN TIKUV IPLARINI ISHLAB CHIQARISH
- CONDUCTING RESEARCH ON IDENTIFICATION AND ELIMINATION OF ERRORS ARISING WHEN PROCESSING COMPLEX SHAPED PARTS ON CNC MACHINES
- FARG’ONA VILOYATI PAXTA TERISH MASHINALARINING ZAMONAVIY TEXNOLOGIYALARGA INTEGRATSIYASINI TADQIQ QILISH
- DETERMINATION OF THE SOWING MOMENT IN THE SLOPE OF THE FLYER
Last modified: 2021-12-27 05:08:43